Court of Appeal rules on public interest immunity material and confidentiality rings
In the context of a CMA investigation into whether or not drug companies were entering into anti-competitive agreements which prolonged high prices for a life-saving drug, on 7 August 2018 the Court of Appeal ruled on certain matters in respect of public interest immunity (PII) material and the use of confidentiality rings.
Also in this newsletter
China’s SAMR publishes its first penalty decisions for failure to notify since agency consolidation
Singapore Competition and Consumer Commission issues proposed infringement decision against the owners/operators of four hotels
UK expert panel will scrutinise competition in the rapidly growing digital economy
UK High Court dismisses application for judicial review of Ofcom decision on ‘fit and proper’ test in Fox/Sky merger
